Detalhe da pesquisa
1.
Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
Parasitology
; 145(4): 508-526, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28691653
2.
Immunological consequences of stress-related proteins--cytosolic tryparedoxin peroxidase and chaperonin TCP20--identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis.
Parasitology
; 142(5): 728-44, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25498563
3.
Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani.
Acta Parasitol
; 65(1): 57-67, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578670
4.
Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.
Front Immunol
; 10: 288, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30873164
5.
Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.
Int J Antimicrob Agents
; 48(6): 695-702, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27876275
6.
Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani.
Front Microbiol
; 7: 312, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27047452
7.
Visceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular Approaches.
Front Immunol
; 5: 380, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25202307